ANIP - Ani Pharmaceuticals Inc
NYSE * Health Care * Pharmaceuticals
$78.31
$-0.05 (-0.06%)
About Ani Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANIP Key Statistics
Market Cap
$1.78B
P/E Ratio
23.59
P/B Ratio
3.30
EPS
$3.32
Revenue Growth
+0.3%
Profit Margin
0.1%
Employees
970
How ANIP Compares to Peers
P/E Rank
#1
of 2
Margin Rank
#2
of 2
Growth Rank
#1
of 2
Size Rank
#2
of 2
Ani Pharmaceuticals Inc Company Information
- Headquarters
- Minnesota; U.S.A
- Website
- www.anipharmaceuticals.com
- Sector
- Health Care
- Industry
- Pharmaceuticals